Compare Mesoblast Limited (MESO) vs Tyson Foods, Inc. (TSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Tyson Foods, Inc. — how do they compare? Mesoblast Limited trades at $13.8 (market cap $1.75B), while Tyson Foods, Inc. trades at $52.29 (market cap $18.41B). The key difference: Tyson Foods, Inc. is far larger — about 10.5× Mesoblast Limited's market cap, and Tyson Foods, Inc. pays a 3.9% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals — on Pluang, investors hold Mesoblast Limited for 14 Days and Tyson Foods, Inc. for 76 Days on average.
| MESO | TSN | |
|---|---|---|
Market Cap | $1.75B | $18.41B |
Volume | 239,027 | 3,757,599 |
Sector | Health | Consumer Staples |
52-Week High | $20.96 | $68.75 |
52-Week Low | $13.19 | $50.47 |
Typical Hold Time | 14 Days | 76 Days |
Enterprise Value | $1.83B | $25.68B |
Dividend Yield | — | 3.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MESO trades at $13.94, up 2.42% with bearish technical signals from moving averages. The company reported substantial revenue growth to $120 million in 2026 but remains unprofitable with a -47.82% net margin. Recent FDA approval for Ryoncil potency assay and completion of Phase 3 back pain trial represent significant operational milestones. Cash position remains strong at $161.16 million, though debt levels require monitoring.
While MESO shows promising revenue growth and pipeline progress, persistent losses and negative ROE present fundamental challenges. Analyst consensus leans bullish with 45% buy ratings, but technical indicators suggest near-term caution. The stock offers speculative growth potential contingent on successful commercialization and path to profitability.
Tyson Foods (TSN) trades at $51.70, down 0.52% on the day, with mixed technical signals showing neutral overall but bearish moving averages. The company reported Q2 2026 EPS of $0.99, beating expectations of $0.989, though revenue growth remains modest at 1.5%-2.0% for fiscal 2026. Valuation metrics show a P/E of 31.91 and P/S of 0.33, with analyst consensus price target at $65.40 representing 26% upside potential.
The stock presents a cautious opportunity with strong analyst support (53% buy ratings) but faces headwinds from beef segment losses and ongoing securities investigations. Upside potential exists if management can stabilize margins and execute on cost controls, though investors should monitor the Q4 earnings release on November 16, 2026 for confirmation of turnaround progress.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Tyson Foods, Inc.
Tyson Foods is the largest U.S. producer of processed chicken and beef. It's also a large producer of processed pork and protein-based products under the brands Jimmy Dean, Hillshire Farm, Ball Park, Sara Lee, Aidells, State Fair, and Raised & Rooted, to name a few. Tyson sells 81% of its products through various U.S. channels, including retailers (47% in fiscal 2021), food service (32%), and other packaged food and industrial companies (10%). In addition, 11% of the company's revenue comes from exports to Canada, Mexico, Brazil, Europe, China, and Japan.
Read more on TSN →
